首页> 外文期刊>Analytical methods >Development and validation of an UHPLC-MS/MS method for the simultaneous determination of four flavonoid glycosides and phellopterin in rat plasma: application to a pharmacokinetic study of oral administration of Poncirus trifoliata extract
【24h】

Development and validation of an UHPLC-MS/MS method for the simultaneous determination of four flavonoid glycosides and phellopterin in rat plasma: application to a pharmacokinetic study of oral administration of Poncirus trifoliata extract

机译:同时测定大鼠血浆中四种类黄酮苷和蝶呤的UHPLC-MS / MS方法的开发和验证:在口服三叶草提取物的药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

A simple, sensitive and selective ultra high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for the simultaneous determination and pharmacokinetic study of five active components, hesperidin, neohesperidin, hesperidin methyl chalcone, poncirin, and phellopterin in rat plasma after oral administration of Poncirus trifoliata extract for the first time. This method involves a simple protein precipitation extraction with acetonitrile. The separation was performed on an Agilent XDB C-18 column (100 x 2.1 mm and 1.8 mu m) by gradient elution using a mobile phase composed of acetonitrile and water containing 0.1% formic acid at a flow rate of 0.35 mL min(-1). Selective reaction monitoring was used for the quantification of the five active components and an internal standard (IS, oroxin B). The method was linear for all analytes over their investigated ranges with all correlation coefficients greater than 0.995. The lower limits of quantification (LLOQ) were 2.0 ng mL(-1) for hesperidin, neohesperidin, hesperidin methyl chalcone, and poncirin, and 1.0 ng mL(-1) for phellopterin. Intra-and inter-day precisions (RSD%) were in the range of 0.8-12.9% and the accuracies were between 87.2 and 108.3%. The developed method was successfully applied to the pharmacokinetic study of hesperidin, neohesperidin, hesperidin methyl chalcone, poncirin, and phellopterin in rat plasma after oral administration of Poncirus trifoliata extract.
机译:建立了一种简单,灵敏且选择性的超高效液相色谱-串联质谱(UHPLC-MS / MS)方法,用于同时测定橙皮苷,新橙皮苷,橙皮苷甲基查尔酮,poncirin和phellopterin的5种活性成分并进行药代动力学研究首次口服三叶草提取物后在大鼠血浆中的作用。该方法涉及用乙腈进行简单的蛋白质沉淀萃取。分离是在Agilent XDB C-18色谱柱(100 x 2.1 mm和1.8μm)上进行的,使用乙腈和水(含0.1%甲酸)组成的流动相以0.35 mL min(-1)的流速进行梯度洗脱)。选择性反应监测用于定量五个活性成分和一个内标(IS,oroxin B)。对于所有分析物在其研究范围内,该方法都是线性的,所有相关系数均大于0.995。橙皮苷,新橙皮苷,橙皮苷甲基查尔酮和poncirin的定量下限(LLOQ)为2.0 ng mL(-1),而鞘磷脂为1.0 ng mL(-1)。日内和日间精度(RSD%)在0.8-12.9%的范围内,精度在87.2和108.3%之间。所开发的方法成功地应用于口服橙皮提取物后橙皮苷,新橙皮苷,橙皮苷甲基查尔酮,poncirin和phellopterin的药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号